lidocaine [Ligand Id: 2623] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL79 (ALGRX 3268, ALGRX-3268, Alphacaine, Dentipatch, Embolex, Iontocaine, Lidocaina, Lidocaine, Lidocaine component of emla, Lidocaine component of fortacin, Lidocaine component of lanabiotic, Lidocaine component of oraqix, Lidocaine component of pliaglis, Lidocaine component of rocephin kit, Lidocaine component of synera, Lidocainum, Lidoderm, Lignocaine hcl, Lmx 4, NSC-40030, Octocaine, Oraqix, Solarcaine, Vagisil, Xylestesin, Xylocaine, Xylodase, Xylotox, Ztlido) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| Nav1.3/Sodium channel protein type 3 subunit alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5163] [GtoPdb: 580] [UniProtKB: Q9NY46] | ||||||||
| ChEMBL | Modulation of human Nav1.3 in open-inactivated state assessed as inhibition of inward current after 4 mins by whole-cell electrophysiology | B | 4.98 | pIC50 | 10500 | nM | IC50 | Eur J Med Chem (2014) 74: 23-30 [PMID:24440379] |
| Nav1.4/Sodium channel protein type 4 subunit alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2072] [GtoPdb: 581] [UniProtKB: P35499] | ||||||||
| ChEMBL | Modulation of human Nav1.4 in open-inactivated state assessed as inhibition of inward current after 4 mins by whole-cell electrophysiology | B | 5.7 | pIC50 | 2000 | nM | IC50 | Eur J Med Chem (2014) 74: 23-30 [PMID:24440379] |
| Nav1.4 in Rat [GtoPdb: 581] [UniProtKB: P15390] | ||||||||
| GtoPdb | - | - | 2.7 | pIC50 | - | - | - | Cardiovasc Res (1999) 42: 503-9 [PMID:10533585] |
| Nav1.5/Sodium channel protein type 5 subunit alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1980] [GtoPdb: 582] [UniProtKB: Q14524] | ||||||||
| GtoPdb | - | - | 4.8 | pKd | - | - | - | J Gen Physiol (1995) 106: 1193-209 [PMID:8786356] |
| ChEMBL | Inhibition of human Nav1.5 in inactivated condition by automated patch-clamp assay | B | 4.3 | pIC50 | 50000 | nM | IC50 | RSC Med Chem (2022) 13: 895-920 [PMID:36092147] |
| Nav1.5 in Rat [GtoPdb: 582] [UniProtKB: P15389] | ||||||||
| GtoPdb | - | - | 4.2 | pIC50 | - | - | - | Mol Pharmacol (1989) 36: 150-9 [PMID:2546048] |
| Nav1.7/Sodium channel protein type 9 subunit alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4296] [GtoPdb: 584] [UniProtKB: Q15858] | ||||||||
| ChEMBL | Modulation of human Nav1.7 in open-inactivated state assessed as inhibition of inward current after 4 mins by whole-cell electrophysiology | B | 4.54 | pIC50 | 29000 | nM | IC50 | Eur J Med Chem (2014) 74: 23-30 [PMID:24440379] |
| ChEMBL | Inhibition of human Nav1.7 in inactivated condition by automated patch-clamp assay | B | 4.8 | pIC50 | 16000 | nM | IC50 | RSC Med Chem (2022) 13: 895-920 [PMID:36092147] |
| Nav1.7 in Rat [GtoPdb: 584] [UniProtKB: O08562] | ||||||||
| GtoPdb | - | - | 3.3 | pIC50 | - | - | - | Br J Pharmacol (2004) 142: 576-84 [PMID:15148257] |
| Nav1.2 in Rat [GtoPdb: 579] [UniProtKB: P04775] | ||||||||
| GtoPdb | - | - | 5 | pIC50 | - | - | - | Proc Natl Acad Sci USA (1996) 93: 9270-5 [PMID:8799190] |
| Nav1.8 in Rat [GtoPdb: 585] [UniProtKB: Q62968] | ||||||||
| GtoPdb | - | - | 4 | pIC50 | - | - | - | Gan To Kagaku Ryoho (1992) 19: 1136-8 [PMID:1514825] |
ChEMBL data shown on this page come from version 36:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
